Overview
What is Crohn's & Colitis Foundation Inc?
For over five decades, the Crohn's & Colitis Foundation Inc, based in New York City, has been at the forefront of research dedicated to finding a cure for Crohn's Disease and Ulcerative Colitis while improving the lives of those affected. With a workforce of 388 employees, the Foundation has provided over $475 million for research, funding priority projects targeting areas with a high potential for advancing treatment. Their innovative research platform, IBD Plexus, is the largest IBD database in the US, with data from over 25,000 patients and 250,000 biosamples. The Foundation is leading the way in critical areas of IBD research, accelerating novel therapies and innovative products to address unmet patient needs. In 2020, they launched the most extensive IBD-focused precision nutrition effort and the Surgical Research Network.
Official website here: www.crohnscolitisfoundation.org
Is Crohn's & Colitis Foundation Inc legitimate?
Crohn's & Colitis Foundation Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Crohn's & Colitis Foundation Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $2,983,632
Professional Fundraising Fees: $569,406
Other Salaries and Wages: $24,396,672
For more financial information, click here
What is the mission statement of Crohn's & Colitis Foundation Inc?
For over five decades, the Crohn's & Colitis Foundation has been dedicated to finding a cure for Crohn's disease and ulcerative colitis, two debilitating digestive diseases. The organization's mission is to improve the lives of children and adults affected by these conditions through extensive research funding. Since its inception, the Foundation has provided over $475 million for research initiatives, focusing on multi-institutional, multi-disciplinary collaborative projects with a high probability of advancing treatment. The Foundation's research portfolio covers basic, translational, and clinical research, with groundbreaking studies and research initiatives contributing significantly to the understanding and treatment of Inflammatory Bowel Diseases (IBD). IBD Plexus, the Foundation's innovative research platform, is the largest IBD database in the US, providing researchers with data from over 25,000 patients and 250,000 biosamples. The Foundation is at the forefront of new research areas and accelerates novel therapies and innovative products to address unmet patient needs. In 2020, the Foundation launched the most extensive IBD-focused precision nutrition effort and the Surgical Research Network, a first-ever coordinated-funding effort to study surgical outcomes in IBD, with over 50 centers participating.
Official website here: www.crohnscolitisfoundation.org
Who is the CEO of Crohn's & Colitis Foundation Inc?
Michael Osso is the President/Ceo(Non-Voting) of Crohn's & Colitis Foundation Inc. The CEO's salary of Crohn's & Colitis Foundation Inc is $653,016 and their total compensation is $740,697.
Official website here: www.crohnscolitisfoundation.org
What is the revenue of Crohn's & Colitis Foundation Inc?
Crohn's & Colitis Foundation Inc's revenue in 2022 was $81,491,223.
Official website here: www.crohnscolitisfoundation.org
Who are the executives of Crohn's & Colitis Foundation Inc and what are their salaries?
The average compensation at Crohn's & Colitis Foundation Inc during 2022 was $70,568. There are 388 employees and 5,842 volunteers at Crohn's & Colitis Foundation Inc.
Here are 43 key members and their salaries (Crohn's & Colitis Foundation Inc's CEO's salary is $653,016 and their total compensation is $740,697):
- Michael Osso (President/Ceo(Non-Voting)) [Trustee/Director]
- Caren Heller (Chief Science Officer)
- Rohit Suri (Chief Technology Officer)
- Michael Elkow (Chief Field Officer)
- Judy Hoffstein (Chief Marketing & Communications Off)
- Allison Coffey (Chief Development Officer)
- John Michael Mize (Evp, Business Development)
- Robert Territo (Cfo/Coo (Thru 06/2022))
- Laura Wingate (Evp, Education, Support & Advocacy)
- Marisa Mayer (Chief Legal Officer)
- Anthony Leon (Svp, It)
- Angela Dobes (Vice President, Ibd Plexus)
- Jack Matarasso (Svp, Digital Marketing)
- Sharon Lungrin (Coo (As Of 07/2022))
- Alessandro Dinello (Treasurer) [Trustee/Director]
- Alex Funderburg (Trustee)
- Amber Backhaus (Trustee)
- Rep Ander Crenshaw (Trustee)
- Annette Martinez (Trustee)
- Armin Rahmanian (Trustee)
- Audra Miller (Trustee (As Of 03/2022))
- Brent Polk Md (Chairman) [Trustee/Director]
- Chase Carpenter (Trustee (As Of 03/2022))
- Daniel Stone (Trustee (As Of 03/2022))
- David Rubin Md (Nsac Chair) [Trustee/Director]
- Deborah Crawford (Trustee)
- Frank Russomano (Trustee)
- Jeffrey Mittleman (Trustee)
- Jodi Yellen (Secretary) [Trustee/Director]
- Joe Monk (Trustee)
- Joel Rosh Md (Trustee)
- Lori Siegel Rabinowitz (Trustee (As Of 03/2022))
- Marcy Beth Nanus (Trustee (Thru 03/2022))
- Mark Murray Phd (Trustee)
- Meena Bewtra (Trustee)
- Michele Kissous-Hunt (Trustee)
- Noel Brown (Trustee)
- Peter Higgins Md Phd Msc (Nsac Chair Elect (As Of 03/2022)) [Trustee/Director]
- Rhonda Bolding (Trustee)
- Sean Kelley (Trustee)
- Tolulope Falaiye Md (Trustee)
- Troy Vollertsen (Trustee)
- Shelby Modell (Co-Founder/Trustee)
Official website here: www.crohnscolitisfoundation.org
Where can I find the form 990 for Crohn's & Colitis Foundation Inc?
The Crohn's & Colitis Foundation Inc’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.crohnscolitisfoundation.org
Learn more at the official website: www.crohnscolitisfoundation.org
Mission Statement of Crohn's & Colitis Foundation Inc
The Crohn's & Colitis Foundation has dedicated itself to finding a cure for Crohn's disease and ulcerative colitis for over five decades. Established in the United States, this esteemed organization has provided over $475 million for research on the treatment and cures of inflammatory bowel diseases (IBD). The Foundation's research initiatives focus on multi-institutional, multi-disciplinary collaborative projects, funding the brightest researchers to advance the understanding and treatment of IBD.
With a commitment to cutting years off the research process, the Crohn's & Colitis Foundation's innovative research platform, IBD Plexus, is the largest IBD database in the country. It provides researchers with data from over 25,000 patients, including 250,000 biosamples. The Foundation leads the way in critical areas of IBD research, accelerating novel therapies and innovative products that address unmet patient needs.
In 2020, the Crohn's & Colitis Foundation launched the most extensive IBD-focused precision nutrition effort to better understand the impact of food on the management of IBD and patient quality of life. Additionally, the organization's first-ever coordinated-funding effort, the Surgical Research Network, involves over 50 centers participating in studying surgical outcomes in IBD. These initiatives demonstrate the Foundation's unwavering dedication to improving the lives of those affected by Crohn's disease and ulcerative colitis.
Impact
This information is meant to be a general summary of Crohn's & Colitis Foundation Inc. Please take the time to review official sources before making any decisions based upon the content provided here.
Thursday, August 15, 2024
Crohn's & Colitis Foundation Inc has a significant impact in the field of Crohn's disease and ulcerative colitis. Since its inception, the foundation has provided over $475 million for research on the treatment and cures of these inflammatory bowel diseases. They fund priority research initiatives that target areas of science with a high probability of advancing treatment, leading to groundbreaking studies and research initiatives.
One of the foundation's key contributions is the IBD Plexus, an innovative research platform that is the single largest IBD database in the US. It provides researchers with data from over 25,000 patients and 250,000 biosamples, accelerating the research process and advancing the understanding and treatment of IBD.
Additionally, the foundation leads in new areas of IBD research, such as launching precision nutrition efforts in 2020 to better understand the impact of food on the management of IBD. They also established the Surgical Research Network, a coordinated-funding effort to study surgical outcomes in IBD with over 50 participating centers. These initiatives demonstrate the foundation's commitment to advancing research, accelerating novel therapies, and addressing unmet patient needs in the field of Crohn's disease and ulcerative colitis.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
IBD PLEXUS DATABASE AC
Revenue
$7,109,626
EDUCATION & CAMP REGIS
Revenue
$186,605
Organization Details
Founding Year
1967
Phone
(800) 932-2423
Principal Officer
Michael Osso
Main Address
733 THIRD AVENUE 510, NEW YORK, NY, 10017
NTEE Category
Code: G90 - Disease
If you are a representative of Crohn's & Colitis Foundation Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.